We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current REVB market cap is 457.63k. The company's latest EPS is USD -0.5717 and P/E is -0.02.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -1.2M | -1.22M | -1.62M | -1.93M | -2.78M |
| Net Income | -1.17M | -1.21M | 6.16M | -1.45M | -2.63M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -4k | -145k | -3.09M | -10.87M | -8.66M |
| Net Income | -4k | -136k | -2.13M | -10.83M | -120k |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 6.6M | 5.5M | 18.12M | 16.04M | 14.22M |
| Total Liabilities | 4.37M | 4.45M | 8.1M | 4.62M | 5.4M |
| Total Equity | 2.23M | 1.05M | 10.02M | 11.42M | 8.82M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 23k | 74.16M | 48.39M | 5.5M | 12.21M |
| Total Liabilities | 27k | 2.95M | 8.4M | 4.45M | 5.57M |
| Total Equity | -4k | 5M | -7.82M | 1.05M | 6.65M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -10.27M | -11.22M | -1.58M | -3.57M | -5.28M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 15.19M | 15.2M | 14.03M | 14.03M | 14.03M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | N/A | -219k | -726k | -11.22M | -7.29M |
| Investing | N/A | -74.04M | 25.74M | N/A | N/A |
| Financing | N/A | 74.27M | -24.95M | 15.2M | 14.03M |
| Market Cap | 457.63k |
| Price to Earnings Ratio | -0.02 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 209.91k |
| Average Volume (1 week) | 23.41k |
| Average Volume (1 Month) | 43.36k |
| 52 Week Change | -92.94% |
| 52 Week High | 39.00 |
| 52 Week Low | 1.7801 |
| Spread (Intraday) | 0.07 (3.14%) |
| Company Name | Revelation Biosciences Inc |
| Address |
16192 coastal hwy lewes, delaware 19958 |
| Website | https:// |
| Industry | blank checks (6770) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
